New York, NY - (ACCESSWIRE) - 12/02/2013 - Growing Stock Report initiates its NASDAQ Active Stock Weekly Watch List adding Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Cell Therapeutics, Inc. (NASDAQ:CTIC), DryShips, Inc. (NASDAQ:DRYS) and FreeSeas Inc. (NASDAQ:FREE)
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a biopharmaceutical company that discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally is currently up (+1.45%) on 802,199 shares traded after Achillion Pharmaceuticals, Inc. announced that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at three upcoming investor conferences: Deutsche Bank 2013 BioFEST on Tuesday, December 3, 2013 at 10:10 a.m. ET at the Four Seasons Hotel Boston in Boston, MA; The 25th Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2013 at 12:30 p.m. ET at The New York Palace Hotel in New York, NY; and Oppenheimer 24th Annual Healthcare Conference onWednesday, December 11, 2013 at 1:35 p.m. ET at the Crowne Plaza Times Square in New York, NY. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is currently up (+61.5%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)Click Here: http://www.growingstockreport.com/Survey.aspx?stock=ACHN&SubId=AW
Cell Therapeutics, Inc. (NASDAQ:CTIC) a company that acquires, develops, and commercializes treatments for cancer is currently up (+4.12%) on 749,475 shares traded after Cell Therapeutics, Inc. today announced that it has received a $5 million milestone payment from Teva Pharmaceutical Industries Ltd. related to the achievement of a sales milestone for TRISENOX arsenic trioxide. Cell Therapeutics, Inc. (NASDAQ:CTIC) is currently up (+111.34%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Cell Therapeutics, Inc. (NASDAQ:CTIC)Click Here: http://www.growingstockreport.com/Survey.aspx?stock=CTIC&SubId=AW
DryShips, Inc. (NASDAQ:DRYS) a company that owns drybulk carriers and tankers that operate worldwide is currently up (+1.10%) on 2,296,957 shares traded. DryShips, Inc. (NASDAQ:DRYS) is currently up (+130.07%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about DryShips, Inc. (NASDAQ:DRYS)Click Here: http://www.growingstockreport.com/Survey.aspx?stock=DRYS&SubId=AW
FreeSeas Inc. (NASDAQ:FREE) a company that through its subsidiaries, provides drybulk shipping services is currently up (+332.07%) on 473,286 shares traded after FreeSeas announced that the company's Amended and Restated Articles of Incorporation were amended to effect a reverse stock split of the company's issued and outstanding common stock at a ratio of one new share for every 5 shares currently outstanding. FreeSeas Inc. (NASDAQ:FREE) is currently up (+876.41%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about FreeSeas Inc. (NASDAQ:FREE)Click Here: http://www.growingstockreport.com/Survey.aspx?stock=FREE&SubId=AW
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.growingstockreport.com/Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Contact Info:Growing Stock Report
[email protected]